We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+9.22%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$124M
AUM Growth
+$14.4M
Cap. Flow
+$8.49M
Cap. Flow %
6.84%
Top 10 Hldgs %
8.4%
Holding
601
New
263
Increased
50
Reduced
50
Closed
238

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.25M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$1.25M
3
HAE icon
Haemonetics
HAE
+$779K
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$759K
5
GDDY icon
GoDaddy
GDDY
+$694K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$858K
2
DXC icon
DXC Technology
DXC
+$821K
3
WST icon
West Pharmaceutical
WST
+$728K
4
LUV icon
Southwest Airlines
LUV
+$717K
5
HWM icon
Howmet Aerospace
HWM
+$650K

Sector Composition

Rank Sector Weight
1 Technology 15.52%
2 Industrials 13.79%
3 Consumer Discretionary 12.99%
4 Healthcare 11.5%
5 Financials 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
151
Iovance Biotherapeutics
IOVA
$2.23B
$329K 0.26%
+11,878
New +$270K
LNW
152
DELISTED
Light & Wonder
LNW
$329K 0.26%
+12,303
New +$317K
MCO icon
153
Moody's
MCO
$82.4B
$329K 0.26%
1,387
+334
+32% +$74.2K
PG icon
154
Procter & Gamble
PG
$343B
$327K 0.26%
+2,615
New +$320K
ISBC
155
DELISTED
Investors Bancorp, Inc.
ISBC
$327K 0.26%
+27,459
New +$329K
OLN icon
156
Olin
OLN
$2.64B
$326K 0.26%
18,903
-1,409
-7% -$25.2K
CRSP icon
157
CRISPR Therapeutics
CRSP
$4.58B
$325K 0.26%
+5,334
New +$291K
WWW icon
158
Wolverine World Wide
WWW
$1.54B
$325K 0.26%
+9,632
New +$300K
AGCO icon
159
AGCO
AGCO
$8.78B
$324K 0.26%
4,199
-1,516
-27% -$116K
CE icon
160
Celanese
CE
$5.09B
$324K 0.26%
2,629
-2,268
-46% -$279K
EPC icon
161
Edgewell Personal Care
EPC
$1.27B
$323K 0.26%
+10,435
New +$337K
PWR icon
162
Quanta Services
PWR
$93.9B
$323K 0.26%
7,922
-6,331
-44% -$258K
THC icon
163
Tenet Healthcare
THC
$20.1B
$322K 0.26%
+8,468
New +$254K
WKC icon
164
World Kinect Corp
WKC
$1.96B
$322K 0.26%
+7,415
New +$310K
HOUS
165
DELISTED
Anywhere Real Estate
HOUS
$320K 0.26%
+33,108
New +$304K
WBD icon
166
Warner Bros
WBD
$64.6B
$320K 0.26%
+9,770
New +$294K
PAYX icon
167
Paychex
PAYX
$40.4B
$319K 0.26%
+3,745
New +$316K
RLJ icon
168
RLJ Lodging Trust
RLJ
$1.87B
$319K 0.26%
+17,997
New +$306K
SYF icon
169
Synchrony
SYF
$23.7B
$319K 0.26%
+8,871
New +$317K
GMED icon
170
Globus Medical
GMED
$10.4B
$318K 0.26%
5,407
+1,341
+33% +$72.8K
WOLF icon
171
Wolfspeed
WOLF
$1.2B
$318K 0.26%
+6,899
New +$322K
GH icon
172
Guardant Health
GH
$19.5B
$317K 0.26%
+4,051
New +$292K
SHOO icon
173
Steven Madden
SHOO
$3.12B
$317K 0.26%
+7,382
New +$298K
ZS icon
174
Zscaler
ZS
$23B
$317K 0.26%
+6,812
New +$316K
AGO icon
175
Assured Guaranty
AGO
$3.78B
$316K 0.25%
+6,441
New +$308K
5 6
7
8 9

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q4 2019 Portfolio in Review

As of Q4 2019, Fox Run Management held 601 positions worth $124M, up 13% from $110M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Fox Run Management deployed $8.49M of net new capital in Q4 2019, opening 263 new positions and adding to 50 existing holdings. Its largest new stake was Haemonetics: 6,441 shares worth $740K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Generac Holdings, an estimated $629K trimmed.

  • Fox Run Management's largest Q4 2019 buy was Haemonetics: 6,441 shares worth $740K.
  • Fox Run Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.25M increase.
  • Fox Run Management's biggest Q4 2019 reduction was Generac Holdings, cutting an estimated $629K.
  • Fox Run Management fully exited Pfizer in Q4 2019, selling an estimated $858K.
  • Fox Run Management's ten largest holdings make up 8.4% of its $124M portfolio in Q4 2019.
  • Fox Run Management opened 263 new positions and closed 238 in Q4 2019.
  • Fox Run Management's portfolio value rose 13% quarter-over-quarter to $124M.

Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.